| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.44e-08 | 5 | 148 | 4 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 4.30e-08 | 6 | 148 | 4 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 8.55e-08 | 16 | 148 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.43e-06 | 188 | 148 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 AMY1A AMY1B NECAB2 AMY1C AMY2A PCDHGB2 FBLN1 FBN1 FBN2 HMCN2 NKD1 CELSR3 HMCN1 NCAN CAPS2 EDEM1 CDH1 LTBP4 | 2.91e-06 | 749 | 148 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphatase binding | PSG1 PSG4 PSG9 CTSC SIGLEC16 NCAM1 SIGLEC10 SIGLEC11 PARD3 CDH1 LILRB5 | 4.53e-06 | 264 | 148 | 11 | GO:0019902 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PRTG ICAM1 SPTBN2 OBSCN ITGA6 DSCAML1 FBLN1 FBN1 RUVBL1 CCN1 ARVCF CDH1 LTBP4 PALLD LILRB5 | 4.00e-05 | 599 | 148 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 5.46e-05 | 2 | 148 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 5.46e-05 | 2 | 148 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 8.36e-05 | 12 | 148 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.08e-04 | 13 | 148 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.37e-04 | 14 | 148 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.95e-04 | 52 | 148 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.34e-04 | 23 | 148 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | sialic acid binding | 8.14e-04 | 25 | 148 | 3 | GO:0033691 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PLXNA3 ICAM1 NMUR1 GFRA4 PLXNB2 PTH1R GPR179 HMCN2 CELSR3 FCGR1A FCGR1BP PTPRK GPR149 SCN7A FCRL4 LTBP4 PALLD LILRB5 PLXNB1 EPHA1 EPHA7 | 1.02e-03 | 1353 | 148 | 21 | GO:0004888 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.02e-03 | 103 | 148 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.12e-03 | 7 | 148 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | filamin binding | 1.27e-03 | 29 | 148 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.27e-03 | 29 | 148 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.82e-03 | 70 | 148 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | integrin binding | 1.96e-03 | 175 | 148 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.02e-03 | 34 | 148 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.12e-03 | 73 | 148 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.38e-03 | 36 | 148 | 3 | GO:0019865 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PRTG PSG1 PCDHGB2 PSG4 PSG9 PLXNB2 DSCAML1 HMCN2 CELSR3 HMCN1 CDH1 PALLD | 8.56e-09 | 187 | 145 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PRTG PSG1 PCDHGB2 PSG4 PSG9 ICAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 HMCN1 ARVCF CDH1 PALLD | 4.70e-08 | 313 | 145 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PDCD1 PRTG METTL3 ADAM19 FSTL3 PSG1 PCDHGB2 PSG4 PSG9 ICAM1 ITGA6 NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 HMCN1 CCN1 ARVCF FUT4 PARD3 CDH1 PALLD EPHA7 | 4.90e-07 | 1077 | 145 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 3.61e-06 | 59 | 145 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PLXNA3 HSPG2 PDCD1 METTL3 ADAM19 FSTL3 PSG1 PSG4 PSG9 ICAM1 ITGA6 PLXNB2 DSCAML1 FBLN1 CCN1 FUT4 CDH1 PLXNB1 EPHA1 EPHA7 | 7.91e-06 | 927 | 145 | 20 | GO:0030155 |
| GeneOntologyBiologicalProcess | cell recognition | 1.14e-05 | 198 | 145 | 9 | GO:0008037 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.28e-05 | 21 | 145 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.28e-05 | 21 | 145 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | PLXNA3 HSPG2 PDCD1 METTL3 PSG1 PSG4 PSG9 PLXNB2 DSCAML1 FBLN1 CDH1 PLXNB1 | 1.41e-05 | 375 | 145 | 12 | GO:0007162 |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.81e-05 | 116 | 145 | 7 | GO:0045670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 3.01e-05 | 85 | 145 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 3.19e-05 | 52 | 145 | 5 | GO:0071526 | |
| GeneOntologyBiologicalProcess | axon guidance | PLXNA3 HSPG2 PRTG NCAM1 DSCAML1 HMCN2 CELSR3 SEMA3B PALLD EPHA7 | 3.47e-05 | 285 | 145 | 10 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | PLXNA3 HSPG2 PRTG NCAM1 DSCAML1 HMCN2 CELSR3 SEMA3B PALLD EPHA7 | 3.57e-05 | 286 | 145 | 10 | GO:0097485 |
| GeneOntologyBiologicalProcess | axonogenesis | PLXNA3 HSPG2 PRTG NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 SEMA3B PARD3 CDH1 PALLD PLXNB1 EPHA7 | 4.73e-05 | 566 | 145 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron recognition | 5.91e-05 | 59 | 145 | 5 | GO:0008038 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response to wounding | 9.24e-05 | 13 | 145 | 3 | GO:0106015 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.17e-04 | 14 | 145 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.46e-04 | 15 | 145 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.46e-04 | 15 | 145 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.46e-04 | 15 | 145 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.46e-04 | 15 | 145 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.51e-04 | 162 | 145 | 7 | GO:0030316 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.75e-04 | 166 | 145 | 7 | GO:0002698 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to wounding | 1.78e-04 | 16 | 145 | 3 | GO:0106014 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.78e-04 | 16 | 145 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | axon development | PLXNA3 HSPG2 PRTG NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 SEMA3B PARD3 CDH1 PALLD PLXNB1 EPHA7 | 1.78e-04 | 642 | 145 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 2.03e-04 | 353 | 145 | 10 | GO:0010721 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.15e-04 | 17 | 145 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.15e-04 | 17 | 145 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.15e-04 | 17 | 145 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 2.17e-04 | 290 | 145 | 9 | GO:0044703 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 2.40e-04 | 294 | 145 | 9 | GO:0044706 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.57e-04 | 18 | 145 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 2.57e-04 | 18 | 145 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 HSPG2 PRTG NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 FARP1 SEMA3B PARD3 CDH1 PALLD PLXNB1 EPHA7 | 2.58e-04 | 748 | 145 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 2.68e-04 | 126 | 145 | 6 | GO:1903035 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 2.92e-04 | 4 | 145 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 3.08e-04 | 182 | 145 | 7 | GO:0002761 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin production | 3.55e-04 | 20 | 145 | 3 | GO:0002638 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.55e-04 | 20 | 145 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 3.63e-04 | 187 | 145 | 7 | GO:0001909 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 3.73e-04 | 134 | 145 | 6 | GO:0045638 | |
| GeneOntologyBiologicalProcess | female pregnancy | 3.88e-04 | 249 | 145 | 8 | GO:0007565 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.88e-04 | 49 | 145 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.12e-04 | 21 | 145 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 4.20e-04 | 50 | 145 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.75e-04 | 22 | 145 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 4.84e-04 | 5 | 145 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 4.84e-04 | 5 | 145 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 4.84e-04 | 5 | 145 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | cell junction organization | CACNB1 PSG1 PSG4 PSG9 SPTBN2 CPEB3 ITGA6 PLXNB2 HMCN2 PTPRK FARP1 NCAN PARD3 CDH1 PALLD PLXNB1 EPHA7 | 5.00e-04 | 974 | 145 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PLXNA3 HSPG2 PRTG NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 FARP1 SEMA3B PARD3 CDH1 PALLD PLXNB1 EPHA7 | 5.36e-04 | 802 | 145 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.44e-04 | 23 | 145 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.44e-04 | 23 | 145 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 6.18e-04 | 24 | 145 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 6.18e-04 | 24 | 145 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 6.18e-04 | 24 | 145 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 6.47e-04 | 337 | 145 | 9 | GO:0006898 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.48e-04 | 56 | 145 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PLXNA3 HSPG2 PRTG NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 FARP1 SEMA3B PARD3 CDH1 PALLD PLXNB1 EPHA7 | 6.65e-04 | 819 | 145 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | bone resorption | 6.74e-04 | 99 | 145 | 5 | GO:0045453 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 6.99e-04 | 25 | 145 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 6.99e-04 | 25 | 145 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 7.03e-04 | 151 | 145 | 6 | GO:1902106 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PLXNA3 HSPG2 PRTG NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 FARP1 SEMA3B PARD3 CDH1 PALLD PLXNB1 EPHA7 | 7.26e-04 | 826 | 145 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | ADAM19 FSTL3 PSG1 PSG4 PSG9 ICAM1 ITGA6 FBLN1 CCN1 FUT4 CDH1 EPHA1 | 8.16e-04 | 579 | 145 | 12 | GO:0045785 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | PDCD1 METTL3 ADAM19 FSTL3 PSG1 PSG4 PSG9 ICAM1 ITGA6 FUT4 CDH1 EPHA7 | 8.28e-04 | 580 | 145 | 12 | GO:0022407 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.80e-04 | 27 | 145 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium-mediated signaling | 8.80e-04 | 27 | 145 | 3 | GO:0050849 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 9.20e-04 | 159 | 145 | 6 | GO:1903707 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 9.80e-04 | 28 | 145 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.09e-03 | 29 | 145 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.32e-03 | 31 | 145 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.34e-03 | 8 | 145 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.45e-03 | 32 | 145 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.45e-03 | 32 | 145 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.45e-03 | 32 | 145 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 1.50e-03 | 70 | 145 | 4 | GO:0009311 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.50e-03 | 70 | 145 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.58e-03 | 71 | 145 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.59e-03 | 33 | 145 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.59e-03 | 33 | 145 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 1.64e-03 | 385 | 145 | 9 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of calcium-mediated signaling | 1.66e-03 | 121 | 145 | 5 | GO:0050848 | |
| GeneOntologyBiologicalProcess | neuron projection development | PLXNA3 HSPG2 PRTG CPEB3 ITGA6 NCAM1 PLXNB2 DSCAML1 HMCN2 CELSR3 PTPRK FARP1 SEMA3B GPC2 PARD3 CDH1 PALLD PLXNB1 EPHA7 | 1.69e-03 | 1285 | 145 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.74e-03 | 34 | 145 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.74e-03 | 34 | 145 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.76e-03 | 389 | 145 | 9 | GO:0022409 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A1BG HSPG2 ADAMTSL1 ADAM19 CTSC ICAM1 ITGA6 NCAM1 PLXNB2 SSPOP FBLN1 FBN1 FBN2 HMCN2 HMCN1 CCN1 P3H2 NCAN SEMA3B ADAMTS20 GPC2 DMBT1 LTBP4 | 2.93e-12 | 530 | 147 | 23 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | A1BG HSPG2 ADAMTSL1 ADAM19 CTSC ICAM1 ITGA6 NCAM1 ADAMTSL3 PLXNB2 SSPOP FBLN1 FBN1 FBN2 HMCN2 HMCN1 CCN1 P3H2 NCAN SEMA3B ADAMTS20 GPC2 DMBT1 LTBP4 | 3.36e-11 | 656 | 147 | 24 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A1BG HSPG2 ADAMTSL1 ADAM19 CTSC ICAM1 ITGA6 NCAM1 ADAMTSL3 PLXNB2 SSPOP FBLN1 FBN1 FBN2 HMCN2 HMCN1 CCN1 P3H2 NCAN SEMA3B ADAMTS20 GPC2 DMBT1 LTBP4 | 3.58e-11 | 658 | 147 | 24 | GO:0030312 |
| GeneOntologyCellularComponent | adherens junction | 2.64e-06 | 212 | 147 | 10 | GO:0005912 | |
| GeneOntologyCellularComponent | side of membrane | PDCD1 TRAF5 EPM2A ADAM19 PSG1 PSG4 PSG9 ICAM1 ITGA6 NCAM1 GFRA4 ABCG1 FCGR1A FCGR1BP FARP1 FCRL4 GPC2 CDH1 LILRB5 | 1.26e-05 | 875 | 147 | 19 | GO:0098552 |
| GeneOntologyCellularComponent | external side of plasma membrane | PDCD1 ADAM19 PSG1 PSG4 PSG9 ICAM1 ITGA6 NCAM1 GFRA4 ABCG1 FCGR1A FCGR1BP FCRL4 LILRB5 | 1.85e-05 | 519 | 147 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | basement membrane | 2.51e-05 | 122 | 147 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | PDCD1 ADAM19 PSG1 PSG4 PSG7 PSG9 ICAM1 ITGA6 NCAM1 GFRA4 PLXNB2 DSCAML1 ABCG1 FCGR1A FCGR1BP PTPRK FCRL4 GPC2 FUT4 CDH1 LILRB5 | 3.39e-05 | 1111 | 147 | 21 | GO:0009986 |
| GeneOntologyCellularComponent | cell-cell junction | KLHL24 CDC42BPA PSG1 PSG4 PSG9 SPTBN2 OBSCN ITGA6 NCAM1 HMCN1 PTPRK ARVCF PARD3 CDH1 | 7.56e-05 | 591 | 147 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 9.25e-05 | 13 | 147 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | microfibril | 9.25e-05 | 13 | 147 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.78e-04 | 16 | 147 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | anchoring junction | HSPG2 KLHL24 CDC42BPA PSG1 PSG4 PSG9 ICAM1 SPTBN2 OBSCN ITGA6 NCAM1 HMCN1 PTPRK ARVCF PARD3 CDH1 PALLD | 5.16e-04 | 976 | 147 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | receptor complex | PLXNA3 TRAF5 PSG1 PSG4 PSG9 ITGA6 GFRA4 PLXNB2 PTH1R PLXNB1 EPHA1 SHISA8 | 8.46e-04 | 581 | 147 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | lateral loop | 1.01e-03 | 7 | 147 | 2 | GO:0043219 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.17e-03 | 254 | 147 | 7 | GO:0000228 | |
| Domain | IGc2 | A1BG HSPG2 PRTG ADAMTSL1 PSG1 PSG4 PSG7 PSG9 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 | 5.43e-19 | 235 | 145 | 23 | SM00408 |
| Domain | Ig_sub2 | A1BG HSPG2 PRTG ADAMTSL1 PSG1 PSG4 PSG7 PSG9 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 | 5.43e-19 | 235 | 145 | 23 | IPR003598 |
| Domain | IG | A1BG HSPG2 PDCD1 PRTG ADAMTSL1 PSG1 PSG4 PSG7 PSG9 ICAM1 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP PTPRK NCAN SEMA3B SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 | 1.86e-18 | 421 | 145 | 28 | SM00409 |
| Domain | Ig_sub | A1BG HSPG2 PDCD1 PRTG ADAMTSL1 PSG1 PSG4 PSG7 PSG9 ICAM1 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP PTPRK NCAN SEMA3B SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 | 1.86e-18 | 421 | 145 | 28 | IPR003599 |
| Domain | Ig-like_fold | A1BG PLXNA3 HSPG2 PDCD1 PRTG ADAMTSL1 EPM2A PSG1 PSG4 PSG7 PSG9 ICAM1 OBSCN NCAM1 ADAMTSL3 PLXNB2 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP PTPRK NCAN SEMA3B SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 PLXNB1 EPHA1 EPHA7 | 5.84e-18 | 706 | 145 | 34 | IPR013783 |
| Domain | - | A1BG PLXNA3 HSPG2 PDCD1 PRTG ADAMTSL1 EPM2A PSG1 PSG4 PSG7 PSG9 ICAM1 OBSCN NCAM1 ADAMTSL3 PLXNB2 DSCAML1 IGSF10 CILP2 HMCN1 FCGR1A FCGR1BP PTPRK NCAN SEMA3B SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 PLXNB1 EPHA1 EPHA7 | 7.33e-18 | 663 | 145 | 33 | 2.60.40.10 |
| Domain | IG_LIKE | A1BG HSPG2 PDCD1 PRTG ADAMTSL1 PSG1 PSG4 PSG7 PSG9 ICAM1 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP PTPRK NCAN SEMA3B SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 | 1.02e-16 | 491 | 145 | 28 | PS50835 |
| Domain | Ig-like_dom | A1BG HSPG2 PDCD1 PRTG ADAMTSL1 PSG1 PSG4 PSG7 PSG9 ICAM1 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 FCGR1A FCGR1BP PTPRK NCAN SEMA3B SIGLEC10 SIGLEC11 FCRL4 PALLD LILRB5 | 1.90e-16 | 503 | 145 | 28 | IPR007110 |
| Domain | ig | A1BG HSPG2 PSG1 PSG4 PSG7 PSG9 OBSCN NCAM1 ADAMTSL3 DSCAML1 HMCN1 FCGR1A FCGR1BP PTPRK SEMA3B SIGLEC10 SIGLEC11 FCRL4 LILRB5 | 5.10e-16 | 190 | 145 | 19 | PF00047 |
| Domain | Immunoglobulin | A1BG HSPG2 PSG1 PSG4 PSG7 PSG9 OBSCN NCAM1 ADAMTSL3 DSCAML1 HMCN1 FCGR1A FCGR1BP PTPRK SEMA3B SIGLEC10 SIGLEC11 FCRL4 LILRB5 | 5.10e-16 | 190 | 145 | 19 | IPR013151 |
| Domain | Ig_2 | A1BG HSPG2 PSG1 PSG4 PSG7 PSG9 FCGR1A FCGR1BP SIGLEC10 FCRL4 LILRB5 | 9.92e-12 | 73 | 145 | 11 | PF13895 |
| Domain | Ig_I-set | HSPG2 PRTG ADAMTSL1 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 PTPRK SIGLEC10 SIGLEC11 PALLD | 2.22e-11 | 190 | 145 | 15 | IPR013098 |
| Domain | I-set | HSPG2 PRTG ADAMTSL1 OBSCN NCAM1 ADAMTSL3 DSCAML1 IGSF10 CILP2 HMCN2 HMCN1 PTPRK SIGLEC10 SIGLEC11 PALLD | 2.22e-11 | 190 | 145 | 15 | PF07679 |
| Domain | Ig_V-set | HSPG2 PDCD1 PSG1 PSG4 PSG7 PSG9 OBSCN DSCAML1 IGSF10 HMCN1 NCAN SIGLEC10 SIGLEC11 | 5.20e-09 | 199 | 145 | 13 | IPR013106 |
| Domain | EGF_2 | HSPG2 ADAM19 ADAM32 SSPOP FBLN1 FBN1 FBN2 HMCN2 CELSR3 HMCN1 NCAN LTBP4 EPHA1 EPHA7 | 1.98e-08 | 265 | 145 | 14 | PS01186 |
| Domain | Growth_fac_rcpt_ | HSPG2 GPR179 FBLN1 FBN1 FBN2 HMCN2 HMCN1 CCN1 LTBP4 EPHA1 EPHA7 | 3.75e-08 | 156 | 145 | 11 | IPR009030 |
| Domain | EGF-like_CS | HSPG2 ADAM19 ADAM32 FBLN1 FBN1 FBN2 HMCN2 CELSR3 HMCN1 NCAN LTBP4 EPHA1 EPHA7 | 1.29e-07 | 261 | 145 | 13 | IPR013032 |
| Domain | - | 2.38e-07 | 8 | 145 | 4 | 3.90.290.10 | |
| Domain | EGF_3 | HSPG2 ADAM19 ADAM32 SSPOP FBLN1 FBN1 FBN2 HMCN2 CELSR3 HMCN1 NCAN LTBP4 | 3.08e-07 | 235 | 145 | 12 | PS50026 |
| Domain | TB_dom | 4.26e-07 | 9 | 145 | 4 | IPR017878 | |
| Domain | TB | 4.26e-07 | 9 | 145 | 4 | PS51364 | |
| Domain | EGF_CA | 4.63e-07 | 122 | 145 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.31e-07 | 124 | 145 | 9 | IPR001881 | |
| Domain | TSP_1 | 5.66e-07 | 63 | 145 | 7 | PF00090 | |
| Domain | TSP1 | 7.02e-07 | 65 | 145 | 7 | SM00209 | |
| Domain | TSP1_rpt | 7.02e-07 | 65 | 145 | 7 | IPR000884 | |
| Domain | TSP1 | 7.02e-07 | 65 | 145 | 7 | PS50092 | |
| Domain | EGF_1 | HSPG2 ADAM19 ADAM32 SSPOP FBLN1 FBN1 FBN2 HMCN2 CELSR3 HMCN1 NCAN LTBP4 | 7.35e-07 | 255 | 145 | 12 | PS00022 |
| Domain | ASX_HYDROXYL | 1.11e-06 | 100 | 145 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.73e-06 | 106 | 145 | 8 | IPR000152 | |
| Domain | Alpha_amylase | 1.82e-06 | 4 | 145 | 3 | IPR006046 | |
| Domain | Aamy_C | 1.82e-06 | 4 | 145 | 3 | SM00632 | |
| Domain | EGF-like_dom | HSPG2 ADAM19 ADAM32 FBLN1 FBN1 FBN2 HMCN2 CELSR3 HMCN1 NCAN LTBP4 | 3.99e-06 | 249 | 145 | 11 | IPR000742 |
| Domain | Alpha-amylase_C | 4.53e-06 | 5 | 145 | 3 | PF02806 | |
| Domain | A-amylase/branching_C | 4.53e-06 | 5 | 145 | 3 | IPR006048 | |
| Domain | EGF_Ca-bd_CS | 1.05e-05 | 97 | 145 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.21e-05 | 99 | 145 | 7 | PS01187 | |
| Domain | V-set | 1.38e-05 | 184 | 145 | 9 | PF07686 | |
| Domain | EGF | 1.54e-05 | 235 | 145 | 10 | SM00181 | |
| Domain | Glyco_hydro_13_cat_dom | 1.57e-05 | 7 | 145 | 3 | IPR006047 | |
| Domain | TB | 1.57e-05 | 7 | 145 | 3 | PF00683 | |
| Domain | Alpha-amylase | 1.57e-05 | 7 | 145 | 3 | PF00128 | |
| Domain | Aamy | 1.57e-05 | 7 | 145 | 3 | SM00642 | |
| Domain | IGv | 2.56e-05 | 75 | 145 | 6 | SM00406 | |
| Domain | Plexin_cytopl | 3.72e-05 | 9 | 145 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 3.72e-05 | 9 | 145 | 3 | IPR013548 | |
| Domain | Plexin | 3.72e-05 | 9 | 145 | 3 | IPR031148 | |
| Domain | cEGF | 4.56e-05 | 26 | 145 | 4 | PF12662 | |
| Domain | cEGF | 4.56e-05 | 26 | 145 | 4 | IPR026823 | |
| Domain | EGF_CA | 5.57e-05 | 86 | 145 | 6 | PF07645 | |
| Domain | TMEM191C | 5.99e-05 | 2 | 145 | 2 | PF15194 | |
| Domain | TMEM191B/C | 5.99e-05 | 2 | 145 | 2 | IPR028186 | |
| Domain | Semap_dom | 9.32e-05 | 31 | 145 | 4 | IPR001627 | |
| Domain | SEMA | 9.32e-05 | 31 | 145 | 4 | PS51004 | |
| Domain | Sema | 9.32e-05 | 31 | 145 | 4 | SM00630 | |
| Domain | Sema | 9.32e-05 | 31 | 145 | 4 | PF01403 | |
| Domain | Plexin_repeat | 1.06e-04 | 32 | 145 | 4 | IPR002165 | |
| Domain | PSI | 1.06e-04 | 32 | 145 | 4 | PF01437 | |
| Domain | A-amylase_C | 1.79e-04 | 3 | 145 | 2 | IPR031319 | |
| Domain | FBN | 1.79e-04 | 3 | 145 | 2 | IPR011398 | |
| Domain | Glyco_hydro_b | 1.95e-04 | 15 | 145 | 3 | IPR013780 | |
| Domain | fn3 | 2.75e-04 | 162 | 145 | 7 | PF00041 | |
| Domain | DUF1605 | 2.88e-04 | 17 | 145 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 2.88e-04 | 17 | 145 | 3 | PF07717 | |
| Domain | HA2 | 3.43e-04 | 18 | 145 | 3 | SM00847 | |
| Domain | RasGAP_dom | 3.43e-04 | 18 | 145 | 3 | IPR001936 | |
| Domain | HA2 | 3.43e-04 | 18 | 145 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 3.43e-04 | 18 | 145 | 3 | IPR007502 | |
| Domain | Neural_cell_adh | 3.56e-04 | 4 | 145 | 2 | IPR009138 | |
| Domain | G2F | 3.56e-04 | 4 | 145 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 3.56e-04 | 4 | 145 | 2 | PS50993 | |
| Domain | GFP | 3.56e-04 | 4 | 145 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 3.56e-04 | 4 | 145 | 2 | IPR006605 | |
| Domain | PSI | 3.72e-04 | 44 | 145 | 4 | IPR016201 | |
| Domain | PSI | 4.41e-04 | 46 | 145 | 4 | SM00423 | |
| Domain | TMEM132D_N | 5.89e-04 | 5 | 145 | 2 | PF15705 | |
| Domain | TMEM132D_C | 5.89e-04 | 5 | 145 | 2 | PF15706 | |
| Domain | TMEM132_M | 5.89e-04 | 5 | 145 | 2 | IPR031437 | |
| Domain | TMEM132_C | 5.89e-04 | 5 | 145 | 2 | IPR031436 | |
| Domain | TMEM132_N | 5.89e-04 | 5 | 145 | 2 | IPR031435 | |
| Domain | TMEM132 | 5.89e-04 | 5 | 145 | 2 | IPR026307 | |
| Domain | TMEM132 | 5.89e-04 | 5 | 145 | 2 | PF16070 | |
| Domain | FN3 | 6.11e-04 | 185 | 145 | 7 | SM00060 | |
| Domain | Peptidase_M12B_ADAM-TS | 8.23e-04 | 24 | 145 | 3 | IPR013273 | |
| Domain | Galactose-bd-like | 8.30e-04 | 94 | 145 | 5 | IPR008979 | |
| Domain | Glyco_hydro_13 | 8.80e-04 | 6 | 145 | 2 | IPR015902 | |
| Domain | FN3 | 9.39e-04 | 199 | 145 | 7 | PS50853 | |
| Domain | IPT | 1.17e-03 | 27 | 145 | 3 | SM00429 | |
| Domain | FN3_dom | 1.25e-03 | 209 | 145 | 7 | IPR003961 | |
| Domain | Carb-bd-like_fold | 1.63e-03 | 8 | 145 | 2 | IPR013784 | |
| Domain | TIG | 1.76e-03 | 31 | 145 | 3 | PF01833 | |
| Domain | IPT | 1.93e-03 | 32 | 145 | 3 | IPR002909 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.50e-03 | 35 | 145 | 3 | IPR002464 | |
| Domain | - | 2.51e-03 | 73 | 145 | 4 | 2.60.120.260 | |
| Domain | VWFC_1 | 2.71e-03 | 36 | 145 | 3 | PS01208 | |
| Domain | VWFC_2 | 3.17e-03 | 38 | 145 | 3 | PS50184 | |
| Domain | VWC | 3.17e-03 | 38 | 145 | 3 | SM00214 | |
| Domain | Glyco_hydro_catalytic_dom | 3.17e-03 | 38 | 145 | 3 | IPR013781 | |
| Domain | DEAH_ATP_HELICASE | 3.17e-03 | 38 | 145 | 3 | PS00690 | |
| Domain | Pep_M12B_propep | 3.41e-03 | 39 | 145 | 3 | PF01562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.14e-07 | 9 | 109 | 4 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.07e-06 | 11 | 109 | 4 | M1091 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 ADAM19 ICAM1 ITGA6 NCAM1 FBLN1 FBN1 FBN2 P3H2 NCAN CDH1 LTBP4 | 3.44e-06 | 300 | 109 | 12 | M610 |
| Pathway | REACTOME_DIGESTION | 2.67e-05 | 23 | 109 | 4 | M27790 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.08e-05 | 258 | 109 | 10 | MM14572 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 6.00e-05 | 28 | 109 | 4 | M27837 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.20e-04 | 143 | 109 | 7 | M27275 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.24e-04 | 63 | 109 | 5 | M11187 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.84e-04 | 37 | 109 | 4 | M27134 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.26e-04 | 39 | 109 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.26e-04 | 39 | 109 | 4 | MM15165 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.02e-04 | 42 | 109 | 4 | M7169 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.62e-04 | 44 | 109 | 4 | M26969 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 4.66e-04 | 20 | 109 | 3 | M27258 | |
| Pathway | KEGG_AXON_GUIDANCE | 4.90e-04 | 129 | 109 | 6 | M5539 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.06e-04 | 85 | 109 | 5 | M16441 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.88e-04 | 52 | 109 | 4 | M14171 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.11e-04 | 250 | 109 | 8 | M27554 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 1.03e-03 | 26 | 109 | 3 | M708 | |
| Pubmed | A1BG PRTG PSG1 PSG4 PSG9 OBSCN DSCAML1 IGSF10 HMCN1 PTPRK SEMA3B | 1.26e-10 | 162 | 149 | 11 | 25826454 | |
| Pubmed | HSPG2 ADAMTSL1 CTSC PLXNB2 SSPOP FBN1 FBN2 HMCN2 HMCN1 DMBT1 LTBP4 | 2.89e-10 | 175 | 149 | 11 | 28071719 | |
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 2423416 | ||
| Pubmed | 6.10e-10 | 11 | 149 | 5 | 7608209 | ||
| Pubmed | 1.24e-09 | 75 | 149 | 8 | 20637190 | ||
| Pubmed | HSPG2 ADAMTSL1 ADAM19 PLXNB2 FBLN1 FBN1 HMCN2 HMCN1 DMBT1 LTBP4 | 3.06e-09 | 167 | 149 | 10 | 22159717 | |
| Pubmed | 3.44e-09 | 54 | 149 | 7 | 8482578 | ||
| Pubmed | 4.82e-09 | 6 | 149 | 4 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 4.82e-09 | 6 | 149 | 4 | 2788608 | |
| Pubmed | 4.82e-09 | 6 | 149 | 4 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 4.82e-09 | 6 | 149 | 4 | 6608795 | |
| Pubmed | 4.82e-09 | 6 | 149 | 4 | 2081604 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.12e-08 | 7 | 149 | 4 | 7794280 | |
| Pubmed | 2.23e-08 | 8 | 149 | 4 | 12414807 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 32697825 | ||
| Pubmed | SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders. | 7.71e-08 | 3 | 149 | 3 | 24859880 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 7.71e-08 | 3 | 149 | 3 | 21827821 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 15299664 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 22063648 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 30982860 | ||
| Pubmed | The role of Siglec-G on B cells in autoimmune disease and leukemia. | 7.71e-08 | 3 | 149 | 3 | 38042621 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 12527308 | ||
| Pubmed | The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells. | 7.71e-08 | 3 | 149 | 3 | 24790146 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 17572677 | ||
| Pubmed | Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. | 7.71e-08 | 3 | 149 | 3 | 23836061 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 25588701 | ||
| Pubmed | 9.67e-08 | 52 | 149 | 6 | 26633812 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.04e-07 | 11 | 149 | 4 | 7493641 | |
| Pubmed | 2.24e-07 | 13 | 149 | 4 | 8294906 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PLXNA3 HSPG2 FSTL3 CTSC ITGA6 PLXNB2 IGSF10 FBLN1 FBN1 FBN2 RUVBL1 CELSR3 CCN1 PTPRK P3H2 SEMA3B EDEM1 PALLD MFSD5 PLXNB1 | 2.29e-07 | 1201 | 149 | 20 | 35696571 |
| Pubmed | Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. | 3.07e-07 | 4 | 149 | 3 | 17912374 | |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 3.07e-07 | 4 | 149 | 3 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 3.07e-07 | 4 | 149 | 3 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 3.07e-07 | 4 | 149 | 3 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 3.07e-07 | 4 | 149 | 3 | 26098870 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 20200274 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 3.07e-07 | 4 | 149 | 3 | 4745489 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 20729333 | ||
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 3.07e-07 | 4 | 149 | 3 | 94264 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 3872721 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 30143587 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 3.07e-07 | 4 | 149 | 3 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 3.07e-07 | 4 | 149 | 3 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 3.07e-07 | 4 | 149 | 3 | 2987507 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 6091898 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 3.07e-07 | 4 | 149 | 3 | 6162108 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 16152770 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 24600033 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 3.07e-07 | 4 | 149 | 3 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 3.07e-07 | 4 | 149 | 3 | 2989529 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 12429738 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 6160849 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 20038598 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 3.07e-07 | 4 | 149 | 3 | 1141004 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 3.07e-07 | 4 | 149 | 3 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 3.07e-07 | 4 | 149 | 3 | 6207174 | |
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 3.07e-07 | 4 | 149 | 3 | 8543783 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 2410924 | ||
| Pubmed | Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. | 3.07e-07 | 4 | 149 | 3 | 24695850 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 3.07e-07 | 4 | 149 | 3 | 2332419 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 25252961 | ||
| Pubmed | 3.13e-07 | 14 | 149 | 4 | 22955271 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 5.27e-07 | 37 | 149 | 5 | 34323105 | |
| Pubmed | 5.32e-07 | 162 | 149 | 8 | 23012479 | ||
| Pubmed | 6.91e-07 | 39 | 149 | 5 | 1676977 | ||
| Pubmed | Organization and chromosomal locations of Rap1a/Krev sequences in the mouse. | 7.37e-07 | 17 | 149 | 4 | 1617222 | |
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 7.37e-07 | 17 | 149 | 4 | 17626059 | |
| Pubmed | 7.37e-07 | 17 | 149 | 4 | 31676858 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 6529441 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 6176569 | ||
| Pubmed | CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. | 7.66e-07 | 5 | 149 | 3 | 19264983 | |
| Pubmed | Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice. | 7.66e-07 | 5 | 149 | 3 | 25987743 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 32737150 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 7.66e-07 | 5 | 149 | 3 | 23493297 | |
| Pubmed | A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing. | 7.66e-07 | 5 | 149 | 3 | 21623346 | |
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 7.66e-07 | 5 | 149 | 3 | 34276419 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 1348427 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 36969253 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 7.66e-07 | 5 | 149 | 3 | 8661735 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 27548433 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 26947073 | ||
| Pubmed | 7.69e-07 | 117 | 149 | 7 | 17145500 | ||
| Pubmed | 9.45e-07 | 18 | 149 | 4 | 34446743 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 2002257 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 1.53e-06 | 6 | 149 | 3 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 1.53e-06 | 6 | 149 | 3 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 1.53e-06 | 6 | 149 | 3 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 1.53e-06 | 6 | 149 | 3 | 7859283 | |
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 14559209 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 1.53e-06 | 6 | 149 | 3 | 1021597 | |
| Pubmed | 1.79e-06 | 47 | 149 | 5 | 24357327 | ||
| Pubmed | 2.23e-06 | 22 | 149 | 4 | 11696558 | ||
| Pubmed | 2.45e-06 | 50 | 149 | 5 | 23658023 | ||
| Interaction | BTNL2 interactions | 1.59e-05 | 155 | 144 | 8 | int:BTNL2 | |
| Interaction | PSG3 interactions | 1.65e-05 | 22 | 144 | 4 | int:PSG3 | |
| Cytoband | 1p21 | 1.08e-06 | 24 | 149 | 4 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 4.24e-04 | 107 | 149 | 4 | chr1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 6.11e-04 | 316 | 149 | 6 | chr3p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 7.65e-04 | 330 | 149 | 6 | chr22q13 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | HSPG2 PRTG ADAMTSL1 OBSCN SIGLEC16 NCAM1 ADAMTSL3 DSCAML1 IGSF10 HMCN2 HMCN1 SIGLEC11 PALLD | 1.92e-11 | 161 | 111 | 13 | 593 |
| GeneFamily | Immunoglobulin like domain containing | A1BG HSPG2 ICAM1 ADAMTSL3 DSCAML1 CILP2 HMCN2 FCGR1A FCGR1BP PTPRK SEMA3B FCRL4 | 2.44e-09 | 193 | 111 | 12 | 594 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.30e-07 | 11 | 111 | 4 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.38e-06 | 163 | 111 | 8 | 590 | |
| GeneFamily | Fibulins | 1.23e-05 | 8 | 111 | 3 | 556 | |
| GeneFamily | Plexins | 1.84e-05 | 9 | 111 | 3 | 683 | |
| GeneFamily | Fibronectin type III domain containing | 5.86e-05 | 160 | 111 | 7 | 555 | |
| GeneFamily | DEAH-box helicases | 1.19e-04 | 16 | 111 | 3 | 500 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.57e-04 | 394 | 111 | 10 | 471 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 6.60e-04 | 28 | 111 | 3 | 745 | |
| GeneFamily | ADAMTS like | 7.69e-04 | 7 | 111 | 2 | 947 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.89e-03 | 40 | 111 | 3 | 592 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.24e-03 | 14 | 111 | 2 | 1095 | |
| GeneFamily | INO80 complex |SRCAP complex | 3.72e-03 | 15 | 111 | 2 | 595 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.19e-03 | 181 | 111 | 5 | 694 | |
| Coexpression | NABA_MATRISOME | PLXNA3 HSPG2 ADAMTSL1 ADAM19 FSTL3 CTSC KCP ADAM32 ADAMTSL3 PLXNB2 SSPOP IGSF10 FBLN1 CILP2 FBN1 FBN2 HMCN2 HMCN1 CCN1 P3H2 NCAN SEMA3B ADAMTS20 GPC2 DMBT1 LTBP4 PLXNB1 | 1.78e-11 | 1008 | 149 | 27 | MM17056 |
| Coexpression | NABA_MATRISOME | PLXNA3 HSPG2 ADAMTSL1 ADAM19 FSTL3 CTSC KCP ADAM32 ADAMTSL3 PLXNB2 SSPOP IGSF10 FBLN1 CILP2 FBN1 FBN2 HMCN2 HMCN1 CCN1 P3H2 NCAN SEMA3B ADAMTS20 GPC2 DMBT1 LTBP4 PLXNB1 | 2.65e-11 | 1026 | 149 | 27 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 KCP SSPOP IGSF10 FBLN1 CILP2 FBN1 FBN2 HMCN2 HMCN1 CCN1 NCAN DMBT1 LTBP4 | 5.09e-10 | 270 | 149 | 14 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 KCP SSPOP IGSF10 FBLN1 CILP2 FBN1 FBN2 HMCN2 HMCN1 CCN1 NCAN DMBT1 LTBP4 | 6.46e-10 | 275 | 149 | 14 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | KCP SSPOP IGSF10 FBLN1 CILP2 FBN1 FBN2 HMCN2 HMCN1 CCN1 DMBT1 LTBP4 | 1.05e-09 | 191 | 149 | 12 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | KCP SSPOP IGSF10 FBLN1 CILP2 FBN1 FBN2 HMCN2 HMCN1 CCN1 DMBT1 LTBP4 | 1.41e-09 | 196 | 149 | 12 | M3008 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.09e-06 | 135 | 149 | 8 | MM965 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_MICROGLIA | PDCD1 CTSC SIGLEC16 DENND2D IGSF10 ELL2 FCGR1A FCGR1BP P3H2 SIGLEC10 SIGLEC11 LILRB5 SMC1B | 8.41e-06 | 516 | 149 | 13 | M40168 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 1.65e-05 | 322 | 149 | 10 | M39060 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 2.62e-05 | 102 | 149 | 6 | M10290 | |
| Coexpression | BHAT_ESR1_TARGETS_VIA_AKT1_UP | 3.47e-05 | 281 | 149 | 9 | M2234 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 4.40e-05 | 164 | 149 | 7 | M41676 | |
| Coexpression | IBRAHIM_NRF1_DOWN | 4.94e-05 | 167 | 149 | 7 | M42512 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | ADAM19 PSG1 PSG4 PSG9 CTSC SIVA1 PLXNB2 ST13 ELL2 CTAGE1 EDEM1 EPHA7 | 5.73e-05 | 534 | 149 | 12 | MM1050 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP | PLXNA3 SPTBN2 DENND2D EPB41L4A PPM1H GPD1L ABCG1 DCAF11 CDH1 PLXNB1 EPHA1 | 6.16e-05 | 455 | 149 | 11 | M17299 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 7.44e-05 | 385 | 149 | 10 | M39264 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.36e-04 | 137 | 149 | 6 | M40313 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.41e-04 | 87 | 149 | 5 | MM851 | |
| Coexpression | GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP | 1.52e-04 | 200 | 149 | 7 | M7279 | |
| Coexpression | GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP | 1.52e-04 | 200 | 149 | 7 | M8433 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN | 1.52e-04 | 200 | 149 | 7 | M7508 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.95e-06 | 122 | 145 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | PLXNA3 HSPG2 CACNB1 ADAMTSL1 FSTL3 LRRC45 KCP NCAM1 GFRA4 PLXNB2 NIBAN3 PTH1R IGSF10 FBLN1 FBN1 FBN2 NKD1 HMCN1 SEMA3B PCYT2 LTBP4 PALLD | 3.09e-05 | 1228 | 145 | 22 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.42e-05 | 97 | 145 | 6 | GSM777043_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.52e-05 | 310 | 145 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.58e-05 | 146 | 145 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ADAMTSL1 ADAM19 NCAM1 PLXNB2 PTH1R IGSF10 FBLN1 FBN1 FBN2 NKD1 HMCN1 CCN1 P3H2 LTBP4 PALLD EPHA7 | 8.43e-05 | 777 | 145 | 16 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.88e-05 | 265 | 145 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.08e-04 | 336 | 145 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | ADAMTSL3 PTH1R TMEM132C IGSF10 FBLN1 FBN1 NKD1 HMCN1 SCN7A PALLD | 1.26e-09 | 196 | 149 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TMEM132C IGSF10 ZNF106 FBLN1 NKD1 HMCN1 CCN1 SCN7A LTBP4 PALLD | 1.33e-09 | 197 | 149 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-08 | 188 | 149 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-08 | 192 | 149 | 9 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-08 | 192 | 149 | 9 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-08 | 192 | 149 | 9 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-08 | 193 | 149 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-08 | 196 | 149 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-08 | 198 | 149 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-08 | 198 | 149 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-08 | 199 | 149 | 9 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-08 | 199 | 149 | 9 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.47e-08 | 199 | 149 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-08 | 199 | 149 | 9 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-08 | 199 | 149 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.58e-08 | 200 | 149 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-08 | 200 | 149 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.58e-08 | 200 | 149 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | distal-1-mesenchymal-Adventitial_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.58e-08 | 200 | 149 | 9 | 738060ed65fa5473fdb39e686f7cdecc059ed92c | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-07 | 178 | 149 | 8 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.66e-07 | 179 | 149 | 8 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-07 | 180 | 149 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-07 | 181 | 149 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-07 | 181 | 149 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-07 | 183 | 149 | 8 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-07 | 186 | 149 | 8 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-07 | 187 | 149 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-07 | 187 | 149 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-07 | 187 | 149 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.31e-07 | 187 | 149 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.41e-07 | 188 | 149 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-07 | 189 | 149 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.61e-07 | 190 | 149 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-07 | 191 | 149 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-07 | 191 | 149 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-07 | 192 | 149 | 8 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-07 | 192 | 149 | 8 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.83e-07 | 192 | 149 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.94e-07 | 193 | 149 | 8 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.94e-07 | 193 | 149 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-07 | 193 | 149 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.94e-07 | 193 | 149 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-07 | 194 | 149 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.18e-07 | 195 | 149 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-07 | 195 | 149 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.18e-07 | 195 | 149 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-07 | 195 | 149 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-07 | 196 | 149 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-07 | 196 | 149 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-07 | 196 | 149 | 8 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-07 | 196 | 149 | 8 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-07 | 196 | 149 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-07 | 197 | 149 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-07 | 198 | 149 | 8 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.58e-07 | 198 | 149 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-07 | 198 | 149 | 8 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.58e-07 | 198 | 149 | 8 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-07 | 198 | 149 | 8 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-07 | 198 | 149 | 8 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.58e-07 | 198 | 149 | 8 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.72e-07 | 199 | 149 | 8 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-07 | 199 | 149 | 8 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.72e-07 | 199 | 149 | 8 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-07 | 199 | 149 | 8 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.72e-07 | 199 | 149 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.86e-07 | 200 | 149 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.86e-07 | 200 | 149 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-07 | 200 | 149 | 8 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.86e-07 | 200 | 149 | 8 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.86e-07 | 200 | 149 | 8 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.86e-07 | 200 | 149 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.86e-07 | 200 | 149 | 8 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.86e-07 | 200 | 149 | 8 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.86e-07 | 200 | 149 | 8 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.86e-07 | 200 | 149 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 169 | 149 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-06 | 176 | 149 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-06 | 179 | 149 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-06 | 181 | 149 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.63e-06 | 181 | 149 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.63e-06 | 181 | 149 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 182 | 149 | 7 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-06 | 182 | 149 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 182 | 149 | 7 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-06 | 183 | 149 | 7 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-06 | 184 | 149 | 7 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.93e-06 | 184 | 149 | 7 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.04e-06 | 185 | 149 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-06 | 186 | 149 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.15e-06 | 186 | 149 | 7 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-06 | 186 | 149 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.27e-06 | 187 | 149 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.27e-06 | 187 | 149 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 188 | 149 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| Computational | Neighborhood of TIMP2 | 1.49e-06 | 46 | 85 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of CDKN1C | 1.93e-06 | 27 | 85 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of KISS1 | 2.18e-06 | 49 | 85 | 6 | GNF2_KISS1 | |
| Computational | Neighborhood of EGFR | 4.67e-06 | 32 | 85 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of MMP11 | 1.86e-05 | 42 | 85 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of IGFBP1 | 1.58e-04 | 35 | 85 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MAGEA9 | PLXNA3 PDCD1 CACNB1 CDC42BPA RBMXL1 PSG1 CPEB3 ADAMTSL3 ELL2 SCN7A LTBP4 | 4.75e-04 | 423 | 85 | 11 | MORF_MAGEA9 |
| Computational | Adhesion molecules. | 8.56e-04 | 141 | 85 | 6 | MODULE_122 | |
| Drug | N-PMT | 1.76e-09 | 4 | 149 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 1.76e-09 | 4 | 149 | 4 | CID003482066 | |
| Drug | SAIB-SG | 1.76e-09 | 4 | 149 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 1.76e-09 | 4 | 149 | 4 | CID013573844 | |
| Drug | Dembrexine | 1.76e-09 | 4 | 149 | 4 | CID000072009 | |
| Drug | g lw | 1.76e-09 | 4 | 149 | 4 | CID000444139 | |
| Drug | beta-santalene | 1.76e-09 | 4 | 149 | 4 | CID000010534 | |
| Drug | Deposiston | 8.76e-09 | 5 | 149 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 8.76e-09 | 5 | 149 | 4 | CID010358258 | |
| Drug | lunularic acid | 8.76e-09 | 5 | 149 | 4 | CID000161413 | |
| Drug | himachalene | 8.76e-09 | 5 | 149 | 4 | CID000015095 | |
| Drug | actinidine | 8.76e-09 | 5 | 149 | 4 | CID000068231 | |
| Drug | 2TAA | 8.76e-09 | 5 | 149 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 8.76e-09 | 5 | 149 | 4 | CID006449879 | |
| Drug | silver perchlorate | 8.76e-09 | 5 | 149 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 8.76e-09 | 5 | 149 | 4 | CID000155287 | |
| Drug | 2-amino-6-picoline | 2.62e-08 | 6 | 149 | 4 | CID000015765 | |
| Drug | phenol blue | 2.62e-08 | 6 | 149 | 4 | CID000075078 | |
| Drug | R 623 | 2.62e-08 | 6 | 149 | 4 | CID003027594 | |
| Drug | Gu-4 | 2.62e-08 | 6 | 149 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 2.62e-08 | 6 | 149 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 2.62e-08 | 6 | 149 | 4 | CID000092801 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.62e-08 | 6 | 149 | 4 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 2.62e-08 | 6 | 149 | 4 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.62e-08 | 6 | 149 | 4 | CID000127364 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 2.62e-08 | 6 | 149 | 4 | CID009577343 | |
| Drug | CNP-G3 | 2.62e-08 | 6 | 149 | 4 | CID003082910 | |
| Drug | AC1OAGH8 | 2.62e-08 | 6 | 149 | 4 | CID006857368 | |
| Drug | vermella | 2.62e-08 | 6 | 149 | 4 | CID000203726 | |
| Drug | hymenin | 2.62e-08 | 6 | 149 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 2.62e-08 | 6 | 149 | 4 | CID000011615 | |
| Drug | AC1L5BOU | 6.07e-08 | 7 | 149 | 4 | CID000174858 | |
| Drug | methyl blue | 6.07e-08 | 7 | 149 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 6.07e-08 | 7 | 149 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 6.07e-08 | 7 | 149 | 4 | CID000071762 | |
| Drug | Paramax | 6.07e-08 | 7 | 149 | 4 | CID000156411 | |
| Drug | BG5P | 6.07e-08 | 7 | 149 | 4 | CID003082752 | |
| Drug | amino-methyl | 6.07e-08 | 7 | 149 | 4 | CID000142005 | |
| Drug | trimitan | 8.98e-08 | 18 | 149 | 5 | CID000005561 | |
| Drug | boric acid gel | 1.21e-07 | 8 | 149 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.21e-07 | 8 | 149 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 1.21e-07 | 8 | 149 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.21e-07 | 8 | 149 | 4 | CID000146692 | |
| Drug | acrinor | 1.21e-07 | 8 | 149 | 4 | CID005489637 | |
| Drug | desethylaprophen | 1.21e-07 | 8 | 149 | 4 | CID000163919 | |
| Drug | NSC300622 | 1.21e-07 | 8 | 149 | 4 | CID000028426 | |
| Drug | theodrenaline | 1.21e-07 | 8 | 149 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.21e-07 | 8 | 149 | 4 | CID000073372 | |
| Drug | azintamide | 1.21e-07 | 8 | 149 | 4 | CID000071105 | |
| Drug | pg 6 | 1.61e-07 | 20 | 149 | 5 | CID000070931 | |
| Drug | GSAD | 2.16e-07 | 9 | 149 | 4 | CID009909127 | |
| Drug | GU-3 | 2.16e-07 | 9 | 149 | 4 | CID000448687 | |
| Drug | alpha-maltosyl fluoride | 2.16e-07 | 9 | 149 | 4 | CID000194237 | |
| Drug | trestatin A | 2.16e-07 | 9 | 149 | 4 | CID003054994 | |
| Drug | zingiberene | 2.16e-07 | 9 | 149 | 4 | CID000092776 | |
| Drug | Atonik | 2.16e-07 | 9 | 149 | 4 | CID000069471 | |
| Drug | H 187 | 2.16e-07 | 9 | 149 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 2.16e-07 | 9 | 149 | 4 | CID000024864 | |
| Drug | AC1N3UXZ | 2.75e-07 | 3 | 149 | 3 | CID004118625 | |
| Drug | AC1LAC07 | 3.59e-07 | 10 | 149 | 4 | CID000485275 | |
| Drug | I ZE | 3.59e-07 | 10 | 149 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 3.59e-07 | 10 | 149 | 4 | CID000012135 | |
| Drug | CG-120 | 3.59e-07 | 10 | 149 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 3.59e-07 | 10 | 149 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 3.59e-07 | 10 | 149 | 4 | CID000126789 | |
| Drug | Glc)4 | 3.59e-07 | 10 | 149 | 4 | CID000189098 | |
| Drug | Ro 20-0083 | 3.59e-07 | 10 | 149 | 4 | CID003082332 | |
| Drug | naphthalene-1,3,6,8-tetrol | 3.59e-07 | 10 | 149 | 4 | CID000440202 | |
| Drug | AC1L3M0Q | 3.59e-07 | 10 | 149 | 4 | CID000118008 | |
| Drug | Rgd Peptide | 5.24e-07 | 239 | 149 | 11 | CID000104802 | |
| Drug | NSC626779 | 5.36e-07 | 46 | 149 | 6 | CID000116733 | |
| Drug | Tempamine | 5.61e-07 | 11 | 149 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 5.61e-07 | 11 | 149 | 4 | CID000164608 | |
| Drug | validamycin D | 5.61e-07 | 11 | 149 | 4 | CID000166726 | |
| Drug | AMO-1618 | 5.61e-07 | 11 | 149 | 4 | CID000017103 | |
| Drug | FG5P | 5.61e-07 | 11 | 149 | 4 | CID000127486 | |
| Drug | AC1L8PXO | 5.61e-07 | 11 | 149 | 4 | CID000430710 | |
| Drug | CNP-G5 | 5.61e-07 | 11 | 149 | 4 | CID000127309 | |
| Drug | HgI2 | 5.61e-07 | 11 | 149 | 4 | CID000024485 | |
| Drug | 2C KM | 5.61e-07 | 11 | 149 | 4 | CID009549196 | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | HSPG2 CACNB1 ABCG1 FBN2 CELSR3 SEMA3B DCAF11 CDH1 PLXNB1 EPHA1 | 7.90e-07 | 199 | 149 | 10 | 6675_DN |
| Drug | C13H9cl2NO5 | 8.07e-07 | 27 | 149 | 5 | CID004369477 | |
| Drug | chloroisocyanuric acid | 8.37e-07 | 12 | 149 | 4 | CID000017921 | |
| Drug | glyciphosphoramide | 8.37e-07 | 12 | 149 | 4 | CID000197092 | |
| Drug | chitosan | 8.37e-07 | 12 | 149 | 4 | CID000071853 | |
| Drug | azaprophen | 8.37e-07 | 12 | 149 | 4 | CID000129486 | |
| Drug | Avenin | 8.37e-07 | 12 | 149 | 4 | CID000095924 | |
| Drug | AC1L4W0B | 8.37e-07 | 12 | 149 | 4 | CID000193311 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 8.37e-07 | 12 | 149 | 4 | CID000072699 | |
| Drug | H2folate | 8.37e-07 | 12 | 149 | 4 | CID000168809 | |
| Drug | calcium cyanamide | 1.17e-06 | 29 | 149 | 5 | CID010920500 | |
| Drug | II 13 | 1.20e-06 | 13 | 149 | 4 | CID003040488 | |
| Drug | pie-like | 1.20e-06 | 13 | 149 | 4 | CID000017384 | |
| Drug | methyl 1'-epiacarviosin | 1.20e-06 | 13 | 149 | 4 | CID000197426 | |
| Drug | isoacarbose | 1.20e-06 | 13 | 149 | 4 | CID000449165 | |
| Drug | AC1NBNXD | 1.20e-06 | 13 | 149 | 4 | CID004470981 | |
| Drug | maackiain | 1.20e-06 | 13 | 149 | 4 | CID000091510 | |
| Drug | GA15 | 1.20e-06 | 13 | 149 | 4 | CID000443453 | |
| Drug | dibromopropanol | 1.20e-06 | 13 | 149 | 4 | CID000007281 | |
| Drug | AC1L9AGE | 1.20e-06 | 13 | 149 | 4 | CID000441043 | |
| Disease | cD177 antigen measurement | 1.58e-06 | 18 | 144 | 4 | EFO_0021866 | |
| Disease | alpha-amylase 1 measurement | 9.36e-06 | 9 | 144 | 3 | EFO_0801371 | |
| Disease | connective tissue disease (implicated_via_orthology) | 7.07e-05 | 3 | 144 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 1.41e-04 | 4 | 144 | 2 | EFO_0801909 | |
| Disease | scoliosis (is_implicated_in) | 1.41e-04 | 4 | 144 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | central corneal thickness | 1.45e-04 | 309 | 144 | 8 | EFO_0005213 | |
| Disease | cutaneous melanoma | 3.26e-04 | 121 | 144 | 5 | EFO_0000389 | |
| Disease | FEV/FEC ratio | HSPG2 ADAM19 NCAM1 MCM7 DENND2D ADAMTSL3 ZNF106 FBLN1 PPARGC1B FBN1 HMCN1 ARVCF CTAGE1 DMBT1 PARD3 LTBP4 | 3.40e-04 | 1228 | 144 | 16 | EFO_0004713 |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 3.50e-04 | 6 | 144 | 2 | EFO_0801907 | |
| Disease | Corneal astigmatism | 5.58e-04 | 77 | 144 | 4 | EFO_1002040 | |
| Disease | obesity (implicated_via_orthology) | 6.75e-04 | 215 | 144 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CACNB1 ADAM19 SPTBN2 OBSCN ADAMTSL3 DSCAML1 ABCG1 FBN2 CDH1 EPHA1 EPHA7 | 6.86e-04 | 702 | 144 | 11 | C0009402 |
| Disease | Liver carcinoma | 8.93e-04 | 507 | 144 | 9 | C2239176 | |
| Disease | retinal vasculature measurement | 1.02e-03 | 517 | 144 | 9 | EFO_0010554 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.04e-03 | 10 | 144 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | nevus count, cutaneous melanoma | 1.05e-03 | 91 | 144 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | cortical thickness | HSPG2 PRTG KLHL24 PSG1 SPTBN2 NCAM1 ADAMTSL3 ZNF106 ABCG1 FBN1 FBN2 ADAMTS20 PARD3 EPHA7 | 1.13e-03 | 1113 | 144 | 14 | EFO_0004840 |
| Disease | corneal resistance factor | 1.73e-03 | 451 | 144 | 8 | EFO_0010067 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.78e-03 | 49 | 144 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | attempted suicide | 1.85e-03 | 178 | 144 | 5 | EFO_0004321 | |
| Disease | cortical surface area measurement | DHX16 PRTG ADAMTSL1 PSG1 NCAM1 ADAMTSL3 PLXNB2 ZNF106 FBN1 FBN2 ADAMTS20 WSCD2 PARD3 WWC1 EPHA7 | 2.45e-03 | 1345 | 144 | 15 | EFO_0010736 |
| Disease | Endometrial Neoplasms | 2.89e-03 | 58 | 144 | 3 | C0014170 | |
| Disease | behavior or behavioral disorder measurement, personality trait | 3.44e-03 | 18 | 144 | 2 | EFO_0004365, EFO_0004782 | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 3.44e-03 | 18 | 144 | 2 | DOID:1273 (is_marker_for) | |
| Disease | Ulcerative Colitis | 3.65e-03 | 63 | 144 | 3 | C0009324 | |
| Disease | skin sensitivity to sun | 3.83e-03 | 19 | 144 | 2 | EFO_0004795 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.83e-03 | 19 | 144 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Dyschondroplasias | 3.83e-03 | 19 | 144 | 2 | C0013366 | |
| Disease | freckles | 4.24e-03 | 20 | 144 | 2 | EFO_0003963 | |
| Disease | pelvic organ prolapse | 4.51e-03 | 136 | 144 | 4 | EFO_0004710 | |
| Disease | electrocardiography | 4.61e-03 | 530 | 144 | 8 | EFO_0004327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQYRSREVQRTCSLE | 51 | Q86VI1 | |
| EAGAGRRALLGRYCQ | 141 | B3EWF7 | |
| IQRACINEKGSDRYR | 76 | Q14507 | |
| ADTGGRQDVRYSVRC | 356 | P21709 | |
| GNYRCSLAGRDLNRN | 411 | Q8NEM8 | |
| EEQRYGLSCGRLGQD | 11 | O00472 | |
| CGALRNLSYGRDTDN | 421 | O00192 | |
| QFDGRIVSRNGRDAC | 296 | Q9BXY5 | |
| QRQDRFYSNCARLSG | 591 | Q96RT6 | |
| DNRNRGRNKARYCAE | 561 | Q02641 | |
| TKAQSYGRGSCRERE | 16 | Q76N32 | |
| GEYGDQNSRLVRAVR | 331 | P45844 | |
| GCNRRELDRYLQSGG | 386 | Q9H013 | |
| YATQNCLGKARERGR | 201 | Q13790 | |
| RNTRLCLAYGGSDVS | 301 | Q9H981 | |
| TARIYDDQGRCQEGL | 311 | Q9HC16 | |
| CQPATARRNSRGRNY | 1231 | Q9UIG0 | |
| CRAQSEGRPCEYNSR | 91 | O00622 | |
| EVRESGLYRCQARGS | 76 | Q96PJ5 | |
| GALYELRSARAQGDC | 171 | Q8NCL9 | |
| YNDATQVRDCRLSGL | 166 | P0DTE7 | |
| YNDATQVRDCRLSGL | 166 | P0DTE8 | |
| NDYEPSCGRSLRRTQ | 776 | Q6RI45 | |
| IQSQSDRFGNCGRDR | 521 | Q8TC27 | |
| YNDATQVRDCRLSGL | 166 | P0DUB6 | |
| LFCADRTERVGRSGN | 716 | Q9H9G7 | |
| GSENVTLCRYRDYRN | 671 | A1A5B4 | |
| EVGLSSCQGDYIRVR | 926 | O60231 | |
| LLERYVTEGRGARCN | 471 | Q7L2E3 | |
| GTQARYVSCRDALDR | 1171 | P59510 | |
| ETDRNGRTGLIVACY | 116 | A6NCL7 | |
| REEEARRQSGAQYGS | 266 | P50502 | |
| LRFQGDSRLEQSGCY | 231 | Q969G9 | |
| GRYRCRVTNKVGSAE | 3361 | P98160 | |
| VTQTLAEAGAYRGCR | 141 | Q8N7Y1 | |
| QTCYREAERSRGRLG | 436 | Q86XR2 | |
| FLLTGDTQGRYRCRS | 81 | P04217 | |
| DTQGRYRCRSGLSTG | 86 | P04217 | |
| YNDATQVRDCRLTGL | 166 | P04746 | |
| SVNDSGEYRCQRGLS | 76 | Q92637 | |
| EAGRALYRQGDRSDC | 651 | Q8IY17 | |
| GRGSAAARSRYTCRL | 271 | Q9HB89 | |
| IAAGGYNREECLRTV | 371 | Q9Y6Y0 | |
| LSQVNCSERYEARGA | 71 | Q6PRD1 | |
| LCELSLGNSAQERYR | 576 | Q8IX03 | |
| SCAETRQVLGARGYS | 31 | Q8N158 | |
| ADLITTCYGGRNRRV | 261 | Q8N335 | |
| TCYGGRNRRVAEAFA | 266 | Q8N335 | |
| NGRDESGANRDCYLL | 4506 | O95714 | |
| NISGCRLLTDRASYG | 216 | P22083 | |
| REGQRCVNLLGSYRC | 4681 | Q8NDA2 | |
| RVNDAQEYRRGGLGS | 66 | Q9UGM5 | |
| CEGRNIRYRTCSNVD | 66 | Q8N6G6 | |
| LRGLEFRGTYCQQRE | 1611 | Q96RV3 | |
| QAGRYRECKRTQGVS | 131 | Q99447 | |
| VRARRNDSGTYLCGA | 111 | Q15116 | |
| RRIQSCYRGEGTLAL | 351 | P51805 | |
| RLANRTRDACYTREG | 331 | O43157 | |
| NRNACYTGTREARDI | 326 | O15031 | |
| TRDRDSGENGEVYCQ | 371 | Q9Y5G2 | |
| DGCLYVFDREQNRRT | 286 | Q8TEB1 | |
| YGCKDALRQQLRSAR | 146 | Q9H4H8 | |
| RSYSRLCRESGAEPQ | 6 | Q96CN5 | |
| RGGSLTLQCRSDVGY | 236 | O75023 | |
| DVQRELARYGAARCG | 186 | Q96KK3 | |
| GYISALRRQLDCVSG | 171 | Q9NSB4 | |
| RANRTGGLYSCDITA | 76 | P23229 | |
| RARCYRSCETQRLGG | 116 | Q8IVL5 | |
| DNGGRNDVTYRILCK | 356 | Q15375 | |
| CQTNRSGGRLYLQTR | 211 | P33993 | |
| SRGRAQVQEFCDYGT | 266 | Q86U44 | |
| RTCNGGQMRRYRTCD | 4771 | Q96RW7 | |
| RRGEQSDEGFYQCLA | 101 | Q2VWP7 | |
| EACRRENRGTLYGTR | 286 | Q86SP6 | |
| DLALGDSGQYVCRAR | 71 | Q5VST9 | |
| DSGQYVCRARNAIGE | 76 | Q5VST9 | |
| TLRDGDRYCLRQDGA | 3311 | Q5VST9 | |
| RGGDRYSLRQDGTRC | 3841 | Q5VST9 | |
| RDAGIYTCIATNRAG | 1201 | Q8WX93 | |
| YVCRECGRGFSRQSV | 636 | Q9NQV7 | |
| RRGYQLSDVDGVTCE | 466 | P23142 | |
| IRKEGRGNYSTDQLC | 641 | Q7Z4Q2 | |
| TTREDAGKYRCAARN | 2401 | Q6WRI0 | |
| QRVLRDGRCSGYTGT | 231 | Q5SVS4 | |
| GRRENGEATDTILCY | 551 | Q6TFL4 | |
| YGSLDLRRECRIGNG | 26 | Q30KQ9 | |
| SPTRCQNGERVERYS | 426 | Q8NE35 | |
| ASGNRREDCEAFRGL | 221 | Q9GZZ7 | |
| GRSNAQIRDYQRIGD | 611 | Q9Y4F1 | |
| QIRDGGVYRCTARNL | 476 | Q8TD84 | |
| GVYRCTARNLVGSAE | 481 | Q8TD84 | |
| RAGYQSTLTRTECRD | 516 | P35555 | |
| RLQVCGSDGATYRDE | 131 | O95633 | |
| NGYFRIRRGTDECAI | 436 | P53634 | |
| QRTGRAGREDSGICY | 401 | Q9H6R0 | |
| NYLRRGREACNEGEG | 401 | Q92611 | |
| QRCENSPGSYRCVRD | 976 | Q8N2S1 | |
| SVNDSGEYRCQRGLS | 76 | P12314 | |
| LEGTYLCRARSTQGE | 451 | P05362 | |
| GFVLSDNGRRCFDTR | 2086 | P35556 | |
| DQDSQRGRSYLRDNV | 2841 | Q9NYQ7 | |
| EACGYYQRRSLRGAQ | 406 | Q86YV9 | |
| NGDGRCQGRVEILYR | 106 | Q9UGM3 | |
| NGGDRCQGRVEVLYR | 606 | Q9UGM3 | |
| NGGDRCQGRVEVLYR | 866 | Q9UGM3 | |
| NGGDRCQGRVEVLYR | 1126 | Q9UGM3 | |
| GDRCQGRVEVLYRGS | 1386 | Q9UGM3 | |
| RGCVLRSKRDVGSYQ | 2376 | Q9UGM3 | |
| SYRQYRRSQCSDGER | 596 | Q9HCS5 | |
| TRNETGPYQCEIRDR | 301 | Q00888 | |
| GNRVENDRERYGNRN | 1006 | O95104 | |
| YDRQRAFSRTCAGGL | 226 | Q6N075 | |
| VLGRVNFEDCTGRQR | 51 | P12830 | |
| LTNVDGSRKIGYCRR | 126 | Q9H6A0 | |
| TRNETGPYQCEIRDR | 301 | P11464 | |
| YLRLTVSRDRQSNGC | 86 | Q8IXS8 | |
| DLYRCVTQSERGSGV | 266 | Q15262 | |
| IRGRGCNESFRAAID | 916 | Q8TEW0 | |
| REVNGCSGVNRYESV | 446 | Q6P4F7 | |
| RSDLYSSCDRVGRQE | 331 | Q96E39 | |
| SRSCGVGQQRRLRAY | 3961 | A2VEC9 | |
| DEEERRGRGCALQYQ | 561 | Q8N3T6 | |
| EERRQSASRGCTLQY | 576 | Q6IEE7 | |
| RCDGQLRGVQYSTES | 241 | P0C7N4 | |
| GRCDGQLRGVQYSTE | 241 | A6NGB0 | |
| GYRARREANARCGVL | 1401 | Q6ZWJ8 | |
| TRNETGPYQCEIRDR | 301 | Q00887 | |
| RASDSGLYRCQVVRG | 131 | O14594 | |
| CEVLTRNRRGEKYGF | 931 | Q86YN6 | |
| DGPRRLDQSRCSNYD | 96 | B8ZZ34 | |
| TRNETGPYQCEIRDR | 301 | Q13046 | |
| GIYTDCQGRRSRQQE | 1431 | Q5VT25 | |
| RLCARAYLNGDGSGR | 441 | O00463 | |
| GSCRRVAVNGLLRDY | 1016 | Q8IUL8 | |
| TYRCEGRILARGEIN | 186 | P13591 | |
| VVYTDGCCSSNGRRR | 141 | O60930 | |
| YCGAGSVSDIIRLRN | 101 | Q13188 | |
| ERGCNVRQTKTYRDR | 41 | Q9UI72 | |
| QEGTRRYRLCNECLA | 356 | Q96BR9 | |
| CRVGDLYSDLRDGRN | 76 | O15020 | |
| IERERSSYNISGGCT | 256 | Q9ULR3 | |
| ETNAGRCDTRQQYRK | 391 | Q03431 | |
| RIIRGGCSEFRFNDN | 96 | Q8NDV3 | |
| RRDSGVYLCAAVEQG | 636 | Q13214 | |
| LGTVYRRGNLNFTCD | 11 | Q15269 | |
| TDRYRRACQSLGQGE | 1016 | Q96HA7 | |
| NSGAVKRQGRCDTYA | 196 | Q9Y265 | |
| RQGDLSCQVRAGLYT | 126 | Q14588 | |
| ERYALLCGNRTDAGQ | 301 | Q01118 | |
| FGIESNQRCDRGSRD | 921 | Q5TAH2 | |
| KICESYNTAQAGGRR | 241 | Q96PM5 | |
| IGCYLDDTQSRALRG | 131 | Q2TBF2 | |
| GDSGRYTCRAENRLG | 316 | Q96LC7 | |
| YTCRAENRLGSQQRA | 321 | Q96LC7 | |
| GSYDCTISVRDARNG | 1676 | Q9H2Y7 | |
| SQRELSRGVCAERYS | 21 | O15304 | |
| AGDSGRYTCRAENRL | 326 | Q96RL6 | |
| QYVLAKRARRCDAGG | 21 | Q9NXG2 | |
| LRACADGGANRLYDI | 41 | Q9H3S4 | |
| SGRYTCRAENRLGSQ | 301 | A6NMB1 | |
| SSVRLCARYQRGECQ | 86 | Q96H79 | |
| RCLTGRNCEGQNIRY | 101 | P82987 | |
| LRQYLRGTTGVRNCF | 306 | Q7Z6G3 |